About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
Is Kroger Stock a Winner in the Grocery Store Industry?
American grocery retailer Kroger (KR) has secured a strong foothold in the industry, with disruptive product and service offerings. So, given its continued commitment and differentiated strategies to boost its operational performance and achieve sustainable growth, is the stock poised to soar in price? Read on to learn our view.
Should You Buy the Dip in Latham Group Stock?
The shares of Latham Group (SWIM) have declined more than 30% in price over the past six months. However, the company's third-quarter revenue grew nearly 27% despite significant supply chain challenges. So, would it be wise to bet on the stock now? Read on, let's find out.
Is Compass Stock a Buy Under $10?
The shares of real estate technology company Compass (COMP) have plunged in price since the company’s stock market debut last year. Although COMP is making efforts to boost its growth with diversified strategies, its weakening financial performance has raised questions regarding its prospects. So, is it worth betting on the stock at its current price level? Read on to learn our view.
2 Dividend Growth Stocks to Add to Your Income Portfolio in January
Because rising concerns about the resurgence of COVID-19 cases and high inflation may keep the stock market under pressure in the short term, we believe it may be wise to bet on high-quality dividend stocks for a consistent source of income. We think Merck & Co. (MRK) and Walgreens Boots (WBA) are examples of fundamentally sound companies that have exhibited sustainable dividend growth over the past years and could be great additions to one’s portfolio now. So, read on.
Buy These 2 Retail REITs With Yields Over 4%
As investors explore strategies to hedge their portfolios against current market volatility—which is being driven by worries related to surging COVID-19 cases and rising inflation—we believe it may be prudent to invest in real estate investment trusts (REITs) Simon Property Group (SPG) and National Retail Properties (NNN), which are currently yielding more than 4%. So, read on to learn more.
After Adding $200 Million to its Stock Buyback Program, is Office Depot a Buy?
Digital workplace technology services provider ODP Corporation's (ODP) shares rallied nearly 6% in price over the past week on investors' optimism surrounding the sale of its CompuCom unit for approximately $305 million, and the addition of $200 million to its stock buyback program. So, we think it would be wise to bet on the stock now? Let's discuss.
Is Discovery a Good Entertainment Stock to Invest In?
Entertainment services platform Discovery Inc. (DISCA) generated double-digit revenue growth in its last reported quarter, driven by new and existing customers. However, given the company's steep decline in net earnings, is its stock an ideal bet in the competitive streaming services industry? Read on to learn our view.
2 Value Stocks to Buy, According to POWR Ratings
Rising concerns about the spread of the COVID-19 omicron variant and potential monetary policy tightening in the near term are expected to keep the stock market volatile for at least the time being. Therefore, we think it could be wise to bet on fundamentally sound stocks Olin Corporation (OLN) and Gates Industrial Corporation (GTES). These names look undervalued at their current price levels. So, let's discuss.
Down 70% in 2021, is Now a Good Time to Scoop Up Shares of TherapeuticsMD?
Shares of leading healthcare company TherapeuticsMD (TXMD) declined by 72.9% in price last year as the company suffered losses and negative cash flows. In addition, given worries surrounding the stock's non-compliance with Nasdaq's listing rules, is it wise to bet on the stock now? Read on, let's find out.